clonidine has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 2 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clonidine was well tolerated but our study was not enough powerful to demonstrate significant superiority compared to placebo in reducing ICDs despite a greater reduction of total QUIP score at 8 weeks." | 3.30 | Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial. ( Anheim, M; Ballanger, B; Bin, S; Boulinguez, P; Caire, C; Danaila, T; Dhelens, C; Duchez, DD; Fatisson, M; Giordana, C; Huddlestone, M; Klinger, H; Laurencin, C; Marques, A; Meoni, S; Nourredine, M; Prange, S; Thobois, S; Timestit, N; Vidal, T, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laurencin, C | 1 |
| Timestit, N | 1 |
| Marques, A | 1 |
| Duchez, DD | 1 |
| Giordana, C | 1 |
| Meoni, S | 1 |
| Huddlestone, M | 1 |
| Danaila, T | 1 |
| Anheim, M | 1 |
| Klinger, H | 1 |
| Vidal, T | 1 |
| Fatisson, M | 1 |
| Caire, C | 1 |
| Nourredine, M | 1 |
| Boulinguez, P | 1 |
| Dhelens, C | 1 |
| Ballanger, B | 1 |
| Prange, S | 1 |
| Bin, S | 1 |
| Thobois, S | 1 |
| Pallanti, S | 1 |
| Bernardi, S | 1 |
| Allen, A | 1 |
| Chaplin, W | 1 |
| Watner, D | 1 |
| DeCaria, CM | 1 |
| Hollander, E | 1 |
1 trial available for clonidine and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial.
Topics: Clonidine; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Humans; Impulsiv | 2023 |
1 other study available for clonidine and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine.
Topics: Adolescent; Adult; Analysis of Variance; Area Under Curve; Clonidine; Disruptive, Impulse Control, a | 2010 |